Quantitative Assessment of Elagolix Enzyme-Transporter Interplay and Drug–Drug Interactions Using Physiologically Based Pharmacokinetic Modeling

被引：0
|
作者：
Manoj S. Chiney
Juki Ng
John P. Gibbs
Mohamad Shebley
机构：
[1] AbbVie,Clinical Pharmacology and Pharmacometrics
来源：
Clinical Pharmacokinetics | 2020年 / 59卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：617 / 627
页数：10
相关论文
共 50 条
  • [41] Prediction of Drug–Drug Interactions Between Opioids and Overdosed Benzodiazepines Using Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation
    Beihong Ji
    Shuhan Liu
    Ying Xue
    Xibing He
    Viet Hoang Man
    Xiang-Qun Xie
    Junmei Wang
    Drugs in R&D, 2019, 19 : 297 - 305
  • [42] Utility of physiologically based pharmacokinetic modeling in predicting and characterizing clinical drug interactions
    Foti, Robert S.
    DRUG METABOLISM AND DISPOSITION, 2025, 53 (01)
  • [43] Physiologically-Based Pharmacokinetic Modeling to Support the Clinical Management of Drug-Drug Interactions With Bictegravir
    Stader, Felix
    Battegay, Manuel
    Marzolini, Catia
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (05) : 1231 - 1239
  • [44] Physiologically Based Pharmacokinetic Modeling of Nilotinib for Drug-Drug Interactions, Pediatric Patients, and Pregnancy and Lactation
    Liu, Xiaomei I.
    Leong, Ruby
    Burckart, Gilbert J.
    Dallmann, Andre
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (03): : 323 - 333
  • [45] PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING OF DISPOSITION AND DRUG-DRUG INTERACTIONS FOR VALPROIC ACID/DIVALPROEX
    Reed, R.
    Conner, T.
    Zhang, T.
    EPILEPSIA, 2017, 58 : S158 - S159
  • [46] Physiologically Based Pharmacokinetic Modeling for Selumetinib to Evaluate Drug-Drug Interactions and Pediatric Dose Regimens
    Cohen-Rabbie, Sarit
    Zhou, Li
    Vishwanathan, Karthick
    Wild, Martin
    Xu, Sherrie
    Freshwater, Tomoko
    Jain, Lokesh
    Schalkwijk, Stein
    Tomkinson, Helen
    Zhou, Diansong
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (11): : 1493 - 1504
  • [47] INVESTIGATING TRANSPORTER-MEDIATED DRUG-DRUG INTERACTIONS (DDIS) OF DASATINIB USING A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL.
    Chang, M.
    Bathena, S.
    Christopher, L.
    Shen, H.
    Roy, A.
    Leil, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S7 - S7
  • [48] Physiologically Based Pharmacokinetic (PBPK) Modeling of Pitavastatin and Atorvastatin to Predict Drug-Drug Interactions (DDIs)
    Peng Duan
    Ping Zhao
    Lei Zhang
    European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 689 - 705
  • [49] Physiologically Based Pharmacokinetic (PBPK) Modeling of Pitavastatin and Atorvastatin to Predict Drug-Drug Interactions (DDIs)
    Duan, Peng
    Zhao, Ping
    Zhang, Lei
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2017, 42 (04) : 689 - 705
  • [50] Application of physiologically based pharmacokinetic modeling in predicting drug-drug interactions for sarpogrelate hydrochloride in humans
    Min, Jee Sun
    Kim, Doyun
    Park, Jung Bae
    Heo, Hyunjin
    Bae, Soo Hyeon
    Seo, Jae Hong
    Oh, Euichaul
    Bae, Soo Kyung
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 2959 - 2972
12345